Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Forkhead box P3 (FOXP3) is currently thought to be the most specific marker for naturally occurring CD4(+)CD25(+) T regulatory cells (nTregs). In mice, expression of FoxP3 is strictly correlated with regulatory activity, whereas increasing evidence suggests that in humans, activated T effector cells (Teffs) may also express FOXP3. In order to better define the role of FOXP3 in human Teff cells, we investigated the intensity and kinetics of expression in ex vivo Teff cells, suppressed Teff cells and Teff cell lines. We found that all dividing Teff cells expressed FOXP3, but only transiently, and at levels that were significantly lower than those in suppressive nTregs. This temporary expression in Teff cells was insufficient to suppress expression of reported targets of FOXP3 repressor activity, including CD127, IL-2 and IFN-gamma, and was not correlated with induction of a nTreg phenotype. Thus expression of FOXP3 is a normal consequence of CD4(+) T cell activation and, in humans, it can no longer be used as an exclusive marker of nTregs. These data indicate that our current understanding of how FOXP3 contributes to immune tolerance in humans needs to be re-evaluated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Moreover, even within Tregs the intensity of FOXP3 expression can change, with naive or resting populations of Tregs expressing lower levels of FOXP3 than activated Tregs [379, 380].”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [380]
The cited source says what the claim attributes to it.
In the citing paper
“Since Tconvs can also upregulate CD25 and FOXP3, and downregulate CD127 [380, 386], it is critical to set gates for all of these markers on resting populations of T cells, typically using blood cells from healthy individuals.”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [380]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
Chen, W., Jin, W., Hardegen, N., Lei, K.-J., Li, L., Marinos, N., McGrady, G., & Wahl, S. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030152 · Cited by 4,699
An essential role for Scurfin in CD4+CD25+ T regulatory cells
Khattri, R., Cox, T., Yasayko, S.-A., & Ramsdell, F. (2003) · Nature Immunology · doi:10.1038/ni909 · Cited by 2,856
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells
Liu, W., Putnam, A. L., Xu-yu, Z., Szot, G. L., Lee, M. R., Zhu, S., Gottlieb, P. A., Kapranov, P., Gingeras, T. R., de St. Groth, B. F., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060772 · Cited by 2,606 · cited 2×
“Recently, it was reported that human nTregs can be distinguished from Teff cells on the basis of low CD127 (IL-7Ra) expression ( 26 , 27), possibly due to the capacity of FOXP3 to interact with and repress the CD127 promoter (26).”
BackgroundRegulatory T Cell Lineage Specification by the Forkhead Transcription Factor Foxp3
Fontenot, J. D., Rasmussen, J. P., Williams, L. M., Dooley, J. L., Farr, A. G., & Rudensky, A. Y. (2005) · Immunity · doi:10.1016/j.immuni.2005.01.016 · Cited by 2,279
Seddiki, N., Santner-Nanan, B., Martinson, J., Zaunders, J., Sasson, S., Landay, A., Solomon, M., Selby, W., Alexander, S. I., Nanan, R., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060468 · Cited by 1,512 · cited 1×
“Recently, it was reported that human nTregs can be distinguished from Teff cells on the basis of low CD127 (IL-7Ra) expression (26, 27 ), possibly due to the capacity of FOXP3 to interact with and repress the CD127 promoter (26).”
BackgroundTNF/TNFR FAMILY MEMBERS IN COSTIMULATION OF T CELL RESPONSES
Watts, T. H. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115839 · Cited by 1,353
Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25– T cells
R.Walker, M., Kasprowicz, D. J., Gersuk, V. H., Bènard, A., Van Landeghen, M., Buckner, J. H., & Ziegler, S. F. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19441 · Cited by 1,245
FOXP3 Controls Regulatory T Cell Function through Cooperation with NFAT
Wu, Y., Borde, M., Heissmeyer, V., Feuerer, M., Lapan, A. D., Stroud, J. C., Bates, D. L., Guo, L., Han, A., Ziegler, S. F., et al. (2006) · Cell · doi:10.1016/j.cell.2006.05.042 · Cited by 1,189
Cited by
Items 101–200 of 875
Regulatory T cells in inflammatory bowel disease
Boden, E. K., & Snapper, S. B. (2008) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e328311f26e · Cited by 142
CCR5 + T-bet + FoxP3 + Effector CD4 T Cells Drive Atherosclerosis
Li, J., McArdle, S., Gholami, A., Kimura, T., Wolf, D., Gerhardt, T., Miller, J., Weber, C., & Ley, K. (2016) · Circulation Research · doi:10.1161/circresaha.116.308648 · Cited by 141
Genome-Wide Identification of Human FOXP3 Target Genes in Natural Regulatory T Cells
Sadlon, T. J., Wilkinson, B. G., Pederson, S., Brown, C. Y., Bresatz, S., Gargett, T., Melville, E. L., Peng, K., D’Andrea, R. J., Glonek, G. G., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000082 · Cited by 141
“In particular, the existence of two major human-specific FOXP3 isoforms (14) with different regulatory capacities (15, 16) and the transient induction of FOXP3 following activation of CD4CD25(2) non-Tregs in humans (17) suggest a degree of species-specific function by, and regulation of, FOXP3.”
BackgroundChronic Graft-Versus-Host Disease (GVHD) in Children
Baird, K., Cooke, K. R., & Schultz, K. R. (2010) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2009.11.003 · Cited by 141
“B-lymphocytes have at least two important functions: production of antibodies and presentation of antigens to T cells, both of which may contribute to cGVHD [32-35].”
BackgroundCD49d provides access to “untouched” human Foxp3+ Treg free of contaminating effector cells
Kleinewietfeld, M., Starke, M., Di Mitri, D., Borsellino, G., Battistini, L., Rötzschke, O., & Falk, K. (2009) · Blood · doi:10.1182/blood-2008-04-150524 · Cited by 140
Fritzsching, B., Fellenberg, J., Moskovszky, L., Sápi, Z., Krenacs, T., Machado, I., Poeschl, J., Lehner, B., Szendrõi, M., Bosch, A. L., et al. (2015) · OncoImmunology · doi:10.4161/2162402x.2014.990800 · Cited by 140
Shen, L.-S., Wang, J., Ding-feng, S., Yuan, X.-L., Dong, P., Li, M.-X., Xue, J., Zhang, F., Ge, H.-L., & Xu, D. (2009) · Clinical Immunology · doi:10.1016/j.clim.2008.11.010 · Cited by 140
Molling, J. W., de Gruijl, T. D., Glim, J. E., Moreno, M., Rozendaal, L., Meijer, C. J. L. M., van den Eertwegh, A. J. M., Scheper, R. J., von Blomberg, M. E., & Bontkes, H. J. (2007) · International Journal of Cancer · doi:10.1002/ijc.22894 · Cited by 138
Hunt, P. W., LANDAY, A. L., Sinclair, E., Martinson, J., Hatano, H., Emu, B., Norris, P. J., Busch, M. P., Martin, J. N., Brooks, C., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015924 · Cited by 147
“function [67,68,69,70,71,72], so the preserved FoxP3 expression described in that study may simply reflect the presence of recently Figure 4.”
BackgroundDynamics of peripheral tolerance and immune regulation mediated by Treg
Sakaguchi, S., Wing, K., & Yamaguchi, T. (2009) · European Journal of Immunology · doi:10.1002/eji.200939688 · Cited by 165
Vukmanovic-Stejic, M., Agius, E., Booth, N., Dunne, P. J., Lacy, K. E., Reed, J. R., Sobande, T. O., Kissane, S., Salmon, M., Rustin, M. H., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35834 · Cited by 131
Bunnag, S., Allanach, K., Jhangri, G. S., Sis, B., Einecke, G., Mengel, M., Mueller, T. F., & Halloran, P. F. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02268.x · Cited by 128
“However, FOXP3 is not an exclusive marker of regulatory capability: most human T cells transiently express FOXP3 during activation (15).”
BackgroundCD8+ Tregs in lupus, autoimmunity, and beyond
Dinesh, R. K., Skaggs, B. J., Cava, A. L., Hahn, B. H., & Singh, R. P. (2010) · Autoimmunity Reviews · doi:10.1016/j.autrev.2010.03.006 · Cited by 143
“While Foxp3 expression has been suggested as a unique marker for the identification of both CD4+ Tregs and CD8+ Tregs, the finding that TCR activation also upregulates Foxp3 expression in cells without significant regulatory capacity [10,50-52] diminishes enthusiasm for this idea.”
BackgroundRegulatory T cells in the central nervous system
Lowther, D. E., & Hafler, D. A. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01130.x · Cited by 127
“In humans, the highest CD25-expressing cells are suppressive in vitro (19, 34), and the populations of CD4 T cells that lack surface expression of CD127 are enriched for FoxP3 (35, 36).”
BackgroundMizukami, Y., Kono, K., Kawaguchi, Y., Akaike, H., Kamimura, K., Sugai, H., & Fujii, H. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604149 · Cited by 126
“However, it was difficult to discriminate T regs from conventional effector T cells that express CD25 intermediately, because effector T cells continuously express CD25 on their cell surface (Zheng et al, 2004; Fontenot et al, 2005; Allan et al, 2007; Pillai et al, 2007).”
BackgroundAn update on regulatory T cells in transplant tolerance and rejection
Li, X. C., & Turka, L. A. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.101 · Cited by 138
“One of the outstanding features is that in humans, FOXP3 is a T-cell activation molecule rather than an exclusive marker of T REG cells, as stimulation of highly purified human T-effector cells is associated with transient expression of FOXP3, and T cells that temporarily acquire FOXP3 do not always show suppressive f…”
BackgroundLow-strength T-cell activation promotes Th17 responses
Purvis, H. A., Stoop, J. N., Mann, J., Woods, S., Kozijn, A. E., Hambleton, S., Robinson, J. H., Isaacs, J. D., Anderson, A. E., & Hilkens, C. M. U. (2010) · Blood · doi:10.1182/blood-2010-03-272153 · Cited by 126
Resolving the identity myth: Key markers of functional CD4+FoxP3+ regulatory T cells
Chen, X., & Oppenheim, J. J. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.05.018 · Cited by 126
“However, FoxP3 expression can also be induced by TCR stimulation of human Teffs which do not have suppressive activity [38].”
BackgroundZhang, B., Zhang, X., Tang, F. L., Zhu, L., Liu, Y., & Lipsky, P. E. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.083543 · Cited by 123
Induced and natural regulatory T cells in human cancer
Whiteside, T. L., Schuler, P., & Schilling, B. (2012) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2012.707184 · Cited by 124
“Because CD25 is also expressed in activated CD4 or CD8 T cells which have no suppressive activity [27], gating on CD4CD25 T cells has to be used for Treg selection.”
BackgroundGARP: a key receptor controlling FOXP3 in human regulatory T cells
Probst‐Kepper, M., Geffers, R., Kröger, A., Viegas, N., Erck, C., Hecht, H. ‐., Lünsdorf, H., Roubin, R., Moharregh‐Khiabani, D., Wagner, K., et al. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00782.x · Cited by 123
“Following T-cell receptor (TCR) activation, human effector CD4 CD25 T (Th) cells up-regulate FOXP3 protein similar to other markers of T-cell activation including CD25 and CTLA4, and produce effector cytokines like IL-2 and interferon- despite the presence of FOXP3 [11–13].”
BackgroundHonaker, Y., Hubbard, N., Xiang, Y., Fisher, L., Hagin, D., Sommer, K., Song, Y., Yang, S. J., Lopez, C., Tappen, T., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aay6422 · Cited by 128
“It is known that expression of FOXP3 and other Treg markers is transiently altered in Teff after activation (31); accordingly, both Teff and mock-edited cells showed moderate expression of Treg-associated markers (such as CD25 and FOXP3 up-regulation) in response to cell activation.”
BackgroundLim, A. Y. F., Tan, D. B. A., Price, P., Kamarulzaman, A., Tan, H.-Y., JAMES, I. R., & French, M. A. (2007) · AIDS · doi:10.1097/qad.0b013e32825eab8b · Cited by 122
“Furthermore, activation-induced expression of FoxP3 did not suppress cytokine production, CD127 expression or proliferation [18].”
BackgroundCoexpression of TIGIT and FCRL3 Identifies Helios+ Human Memory Regulatory T Cells
Bin Dhuban, K., d’Hennezel, E., Nashi, E., Bar-Or, A., Rieder, S., Shevach, E. M., Nagata, S., & Piccirillo, C. A. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401803 · Cited by 117
Morgan, M. D., Day, C. J., Piper, K. P., Khan, N., Harper, L., Moss, P. A. H., & Savage, C. O. S. (2010) · Immunology · doi:10.1111/j.1365-2567.2009.03213.x · Cited by 135
Braza, F., Dugast, E., Panov, I., Paul, C., Vogt, K., Pallier, A., Chesneau, M., Baron, D., Guerif, P., Lei, H., et al. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014050480 · Cited by 121
Origin and functions of pro-inflammatory cytokine producing Foxp3+ regulatory T cells
Pandiyan, P., & Zhu, J. (2015) · Cytokine · doi:10.1016/j.cyto.2015.07.005 · Cited by 120
“Human CD4+ cells are known to express FOXP3 transiently upon TCR activation [105].”
BackgroundRegulatory T Cells: Serious Contenders in the Promise for Immunological Tolerance in Transplantation
Safinia, N., Scottà, C., Vaikunthanathan, T., Lechler, R. I., & Lombardi, G. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00438 · Cited by 136
“As the function of Tregs is highly dependent on the constitutively high expression of FOXP3 (137), many groups have sought to find ways to stabilize its expression.”
BackgroundRegulatory T cells in the tumour microenvironment
Imianowski, C. J., Chen, Q., Workman, C. J., & Vignali, D. A. A. (2025) · Nature reviews. Cancer · doi:10.1038/s41568-025-00832-9 · Cited by 159
“…+ T conv cells have been shown to transiently upregulate low levels of FOXP3 expression upon stimulation, which is not associated with acquisition of suppressive function, providing a potential caveat to defining these cells as a bona fide T reg cell population without further investigation 85–87 .”
Braudeau, C., Racapé, M., Giral, M., Louis, S., Moreau, A., Berthelot, L., Heslan, M., Ashton‐Chess, J., Soulillou, J., & Brouard, S. (2007) · Transplant International · doi:10.1111/j.1432-2277.2007.00537.x · Cited by 116
Inducible reprogramming of human T cells into Treg cells by a conditionally active form of FOXP3
Allan, S., Song-Zhao, G. X., Abraham, T., McMurchy, A. N., & Levings, M. K. (2008) · European Journal of Immunology · doi:10.1002/eji.200838373 · Cited by 116
Self-citationRapid Temporal Control of Foxp3 Protein Degradation by Sirtuin-1
van Loosdregt, J., Brunen, D., Fleskens, V., Pals, C. E. G. M., Lam, E. W. F., & Coffer, P. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019047 · Cited by 116
“CD4 positive T cells stimulated with phorbol 12-myristate 13-acetate (PMA) and Ca ionophore, or anti-CD3 and anti-CD28, transiently express both Foxp3 mRNA and protein [27;38;39].”
BackgroundSchmidt, A., Eriksson, M., Shang, M.-M., Weyd, H., & Tegnér, J. (2016) · PLOS ONE · doi:10.1371/journal.pone.0148474 · Cited by 112
“Some studies demonstrated Treg phenotype or suppressive capacities of Foxp3+ activated human T cells [3,84] while others did not [4,85,86]; yet others did not observe activation-induced transient Foxp3 induction in human Tcons [87].”
BackgroundHuman macrophages induce CD4+Foxp3+ regulatory T cells via binding and re‐release of TGF‐β
Schmidt, A., Zhang, X., Joshi, R. N., Iqbal, S., Wahlund, C., Gabrielsson, S., Harris, R. A., & Tegnér, J. (2016) · Immunology & Cell Biology · doi:10.1038/icb.2016.34 · Cited by 112
Lin, Y., Mahalingam, J., Chiang, J., Su, P., Chu, Y., Lai, H., Fang, J., Huang, C., Chiu, C., & Lin, C. (2013) · International Journal of Cancer · doi:10.1002/ijc.27784 · Cited by 112
“postulated that activated CD4þ T cells might express Foxp3 but without regulatory activity.(20) CD4þFoxp3 T cells might transiently express lower levels of Key words: colorectal cancer, regulatory T cell, effector memory T”
BackgroundGITR subverts Foxp3+ Tregs to boost Th9 immunity through regulation of histone acetylation
Xiao, X., Shi, X., Fan, Y., Zhang, X., Wu, M., Lan, P., Minze, L. J., Fu, Y., Ghobrial, R. M., Liu, W., et al. (2015) · Nature Communications · doi:10.1038/ncomms9266 · Cited by 120
“In certain models, iTregs can be induced and contribute to immune tolerance 2,3 , whereas in others, iTregs lack regulatory functions and may even contribute to tissue pathology 4,5 .”
De Novo Generation and Enhanced Suppression of Human CD4+CD25+ Regulatory T Cells by Retinoic Acid
Wang, J., Huizinga, T. W. J., & Toes, R. E. M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901065 · Cited by 130
Taylor, A. L., & Llewelyn, M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002416 · Cited by 111
“GITR has been shown to be associated with nTregs, but not activated effector T cells (22).”
BackgroundDonor-Derived Mesenchymal Stem Cells Suppress Alloreactivity of Kidney Transplant Patients
Crop, M. J., Baan, C. C., Korevaar, S. S., IJzermans, J. N. M., Alwayn, I. P. J., Weimar, W., & Hoogduijn, M. J. (2009) · Transplantation · doi:10.1097/tp.0b013e31819b3d72 · Cited by 113
Quintana, F. J. (2013) · Immunology · doi:10.1111/imm.12046 · Cited by 110
Popow, I., Leitner, J. M., Grabmeier‐Pfistershammer, K., Majdic, O., Zlabinger, G. J., Kundi, M., & Steinberger, P. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12514 · Cited by 110
“However, in human T cells, FOXP3 expression is not restricted to a regulatory phenotype, since this transcription factor is also induced in nonregulatory T cells (non-Tregs) upon activation (23,31).”
BackgroundBonelli, M. M., von Dalwigk, K., Savitskaya, A., Smolen, J. S., & Scheinecker, C. (2007) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.074690 · Cited by 119
Role of the tumor microenvironment in the pathogenesis of gastric carcinoma
Chung, H. W., & Lim, J.-B. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i7.1667 · Cited by 111
Short-Chain Fatty Acids Augment Differentiation and Function of Human Induced Regulatory T Cells
Hu, M., Alhamwe, B. A., Santner‐Nanan, B., Miethe, S., Harb, H., Renz, H. E., Potaczek, D. P., & Nanan, R. K. H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105740 · Cited by 128
“Some human T cells can transiently up-regulate Foxp3 expression upon in vitro stimulation without acquiring Treg-cell suppressive properties [31,32].”
BackgroundCTLA-4/CD80 pathway regulates T cell infiltration into pancreatic cancer
Bengsch, F., Knoblock, D. M., Liu, A., McAllister, F., & Beatty, G. L. (2017) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-017-2053-4 · Cited by 105
“Using the Human Protein Atlas [15, 16], we first quantified expression of Foxp3, a bona fide marker for Tregs [18, 19], in primary tumors of several solid cancers using immunohistochemistry.”
Rossetti, M. M., Spreafico, R., Saidin, S., Chua, C. J. H., Moshref, M., Leong, J. Y., Tan, Y. K., Thumboo, J., van Loosdregt, J., & Albani, S. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401145 · Cited by 114
“We measured the efficiency of FOXP3 induction (iTregs) or maintenance (eTregs) after a 24 h resting period to allow activationinduced FOXP3 expression to subside (14, 15).”
BackgroundMethodCutting Edge: Human Latency-Associated Peptide+ T Cells: A Novel Regulatory T Cell Subset
Gandhi, R., Farez, M. F., Wang, Y., Kozoriz, D., Quintana, F. J., & Weiner, H. L. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903329 · Cited by 101
“In humans, however, the Foxp3 expression is not restricted to Tregs and can be detected in activated effector T cells (22).”
BackgroundEsposito, M., Ruffini, F., Bellone, M., Gagliani, N., Battaglia, M., Martino, G., & Furlan, R. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.01.001 · Cited by 289
“The stringency of FoxP3 asmarker of true Treg cells has, however, been recently questioned, pointing to the need of additional markers to better define suppressor cell subpopulations in the activated T cell pool both in humans (Allan et al., 2007; Gavin et al., 2006; Roncarolo and Gregori, 2008) and mice (Wei et al.”
BackgroundTassi, E., Gavazzi, F., Albarello, L., Senyukov, V., Longhi, R., Dellabona, P., Doglioni, C., Braga, M., Di Carlo, V., & Protti, M. P. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.9.6595 · Cited by 102
“FoxP3 expression was also evaluated to identify Tr/recently activated effector T cells (46).”
BackgroundMoving to tolerance: Clinical application of T regulatory cells
McMurchy, A. N., Bushell, A., Levings, M. K., & Wood, K. J. (2011) · Seminars in Immunology · doi:10.1016/j.smim.2011.04.001 · Cited by 109
“In addition, simple phenotypic analyses of circulating Tregs may not give clear results because FOXP3 does not exclusively identify Tregs in humans [27-31] and the presence of Treg in the graft rather than the periphery may be a better indicator of outcome [57, 138].”
BackgroundSelf-citationTranscriptional regulation of IL-2 in health and autoimmunity
Crispín, J. C., & Tsokos, G. C. (2008) · Autoimmunity Reviews · doi:10.1016/j.autrev.2008.07.042 · Cited by 104
“Interestingly, its presence in such context does not induce suppression of IL-2 and IFN-γ production [26].”
BackgroundJiang, T. T., Chaturvedi, V., Ertelt, J. M., Kinder, J. M., Clark, D. R., Valent, A. M., Xin, L., & Way, S. S. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400498 · Cited by 110
“Although Foxp3 is expressed exclusively by Tregs in mice (39, 40), FOXP3 expression in humans occurs for both immune-suppressive Tregs and activated effector T cells (41, 42).”
BackgroundMathian, A., Parizot, C., Dorgham, K., Trad, S., Arnaud, L., Larsen, M., Miyara, M., Hié, M., Pietté, J. C., Francès, C., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200709 · Cited by 110
Tumor Microenvironment and Immune Escape
Ferrone, S., & Whiteside, T. L. (2007) · Surgical Oncology Clinics of North America · doi:10.1016/j.soc.2007.08.004 · Cited by 105
T cells out of control—impaired immune regulation in the inflamed joint
Wehrens, E. J., Prakken, B. J., & van Wijk, F. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.149 · Cited by 106
New insights into the role of T cells in pathogenesis of psoriasis and psoriatic arthritis
Karczewski, J., Dobrowolska, A., Rychlewska-Hańczewska, A., & Adamski, Z. (2016) · Autoimmunity · doi:10.3109/08916934.2016.1166214 · Cited by 103
“For example, activated human Th cells might transiently express FoxP3 at a low level without acquiring Treg cell suppressive activity [162].”
BackgroundRegulatory T Helper Cells in Pregnancy and their Roles in Systemic versus Local Immune Tolerance
Ernerudh, J., Berg, G. E., & Mjösberg, J. (2011) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2011.01049.x · Cited by 109
Benevides, L., Cardoso, C. R. D. B., Tiezzi, D. G., Marana, H. R. C., de Andrade, J. M., & Silva, J. S. (2013) · European Journal of Immunology · doi:10.1002/eji.201242951 · Cited by 104
Subcellular localization of FOXP 3 in human regulatory and nonregulatory T cells
Magg, T., Mannert, J., Ellwart, J. W., Schmid, I., & Albert, M. H. (2012) · European Journal of Immunology · doi:10.1002/eji.201141838 · Cited by 114
Miyara, M., Wing, K., & Sakaguchi, S. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.03.001 · Cited by 106
Maintenance of immune tolerance by Foxp3+ regulatory T cells requires CD69 expression
Cortés, J. R., Sánchez‐Díaz, R., Bovolenta, E. R., Barreiro, O., Lasarte, S., Matesanz-Marín, A., Toribio, M. L., Sánchez‐Madrid, F., & Martín, P. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2014.05.007 · Cited by 104
Koyabu, M., Uchida, K., Miyoshi, H., Sakaguchi, Y., Fukui, T., Ikeda, H., Takaoka, M., Hirohara, J., Nishio, A., Uemura, Y., et al. (2010) · Journal of Gastroenterology · doi:10.1007/s00535-010-0199-3 · Cited by 100
“In contrast to murine Foxp3 Tregs, human Foxp3 cells may not be functionally homogenous [46, 47].”
BackgroundFuture prospects for CD8+ regulatory T cells in immune tolerance
Flippe, L., Bézie, S., Anegón, I., & Guillonneau, C. (2019) · Immunological Reviews · doi:10.1111/imr.12812 · Cited by 110
Regulatory T cell function in autoimmune disease
Rajendiran, A., & Tenbrock, K. (2021) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2021.100130 · Cited by 124
CCL22 Recruits CD4-positive CD25-positive Regulatory T Cells into Malignant Pleural Effusion
Qin, X., Shi, H., Deng, J., Liang, Q.-L., Jiang, J., & Ye, Z. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2641 · Cited by 96
Luther, C., Adamopoulou, E., Stoeckle, C., Brucklacher-Waldert, V., Rosenkranz, D., Stoltze, L., Lauer, S., Poeschel, S., Melms, A., & Tolosa, E. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802046 · Cited by 93
“This fact could just simply reflect recently activated and dividing cells present at each time point while the actual Tregs generated in the presence of DCpred,LPS do evolve and exert their suppressor function independent of FOXP3 (33).”
BackgroundSantegoets, S. J. A. M., Turksma, A. W., Suhoski, M. M., Stam, A. G. M., Albelda, S., Hooijberg, E., Scheper, R. J., van den Eertwegh, A. J. M., Gerritsen, W. R., Powell, D. J., et al. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-37 · Cited by 102
“Of note, although FoxP3 expression is generally associated with natural Tregs (nTregs), it has also been described to be transiently upregulated in activated effector T cells, and importantly, this up-regulation has not been associated with suppressive function [36-38].”
BackgroundHelios is a marker, not a driver, of human Treg stability
Lam, A. J., Uday, P., Gillies, J. K., & Levings, M. K. (2022) · European Journal of Immunology · doi:10.1002/eji.202149318 · Cited by 92
Self-citationSantegoets, S. J. A. M., Stam, A. G. M., Lougheed, S. M., Gall, H. E., Scholten, P. E. T., Reijm, M., Jooss, K. U., Sacks, N., Hege, K. M., Lowy, I., et al. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1330-5 · Cited by 97
Induction of Foxp3+ regulatory T cells with histone deacetylase inhibitors
Lucas, J. L., Mirshahpanah, P., Haas-Stapleton, E. J., Asadullah, K., Zollner, T. M., & Numerof, R. P. (2009) · Cellular Immunology · doi:10.1016/j.cellimm.2009.03.004 · Cited by 94
“Thus, this finding contrasts with the non-regulatory activated CD4 T effector cells that express Foxp3 but do not suppress proliferation or cytokine production [29].”
BackgroundResultSchinnerling, K., Rosas, C., Soto, L., Thomas, R., & Aguillón, J. C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00203 · Cited by 103
“In response to stimulation, human CD4+ effector T cells express MHC class II molecules (134) and upregulate FOXP3 without acquiring immunoregulatory functions (135), while mouse T cells do not.”
BackgroundRegulatory T cells fail to suppress CD4+ T‐bet+ T cells in relapsing multiple sclerosis patients
Frisullo, G., Nociti, V., Iorio, R., Patanella, A. K., Caggiula, M., Marti, A., Sancricca, C., Angelucci, F., Mirabella, M., Tonali, P. A., et al. (2009) · Immunology · doi:10.1111/j.1365-2567.2008.02963.x · Cited by 90
Imbalance of regulatory T cells to Th17 cells in IgA nephropathy
Lin, F. F., Jiang, G.-R., Shan, J., Zhu, C. F., Zou, J., & Wu, X. (2012) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2011.652158 · Cited by 96
Revenko, A. S., Carnevalli, L. S., Sinclair, C., Johnson, B., Peter, A., Taylor, M. A., Hettrick, L. A., Chapman, M., Klein, S., Solanki, A., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-003892 · Cited by 96
Foxp3 expression in T regulatory cells and other cell lineages
Devaud, C., Darcy, P. K., & Kershaw, M. H. (2014) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-014-1581-4 · Cited by 102
“For example, conventional activated human CD4+ T cells could transiently express Foxp3 at a low level but did not exhibit suppressive activity [30].”
BackgroundSchneidawind, D., Pierini, A., & Negrin, R. S. (2013) · Blood · doi:10.1182/blood-2013-08-453126 · Cited by 92
“Unfortunately, ex vivo human iTreg suppressive activity appears less stable in some preclinical models, suggesting that FoxP3 expression is not the only factor that naı̈ve CD4(1) T cells require to convert into functional suppressive cells.(40) The lack of knowledge regarding in vivo iTreg phenotype stability, functio…”
BackgroundInada, K., Shima, T., Ito, M., Ushijima, A., & Saito, S. (2014) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2014.09.053 · Cited by 93
“, 2003), but recent data have hown that Foxp3+ expression in humans occurs in oth immunosuppressive Treg cells and non-suppressive nd cytokine-producing effector T cells (Walker et al., 003; Gavin et al., 2006; Allan et al., 2007).”
BackgroundDu, R., Zhao, H., Yan, F., & Li, H. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.1ru0114-010rr · Cited by 87
“However, it was suggested that functional Tregs could develop in the absence of Foxp3 [28–30].”
BackgroundThe Role of Regulatory T Cells in Atopic Dermatitis
Agrawal, R., Wiśniewski, J., & Woodfolk, J. A. (2011) · Current problems in dermatology · doi:10.1159/000323305 · Cited by 93
Li, B., & Greene, M. I. (2008) · Immunology · doi:10.1111/j.1365-2567.2007.02774.x · Cited by 88
Activated T cells complicate the identification of regulatory T cells in rheumatoid arthritis
Aerts, N. E., Dombrecht, E. J., Ebo, D. G., Bridts, C. H., Stevens, W. J., & Clerck, L. S. D. (2008) · Cellular Immunology · doi:10.1016/j.cellimm.2008.04.008 · Cited by 93
“Despite the shorter duration of CD127 absence in their study, this indicates that a proportion of activated T cells would not be distinguishable from nTregs on the basis of low CD127 expression alone [12].”
BackgroundBraga, W. M. T., da Silva, B. R., de Carvalho, A. C., Maekawa, Y. H., Bortoluzzo, A. B., Rizzatti, E. G., Atanackovic, D., & Colleoni, G. W. B. (2014) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-014-1589-9 · Cited by 88
“Despite FOXP3 being considered the most specific marker for naturally occurring CD4+ CD25+ Tregs, dividing activated T effector cells (Teff cells) can express FOXP3 transiently, and at significantly lower levels than suppressive Tregs [24].”
BackgroundT Regulatory Cells Are Markers of Disease Activity in Multiple Sclerosis Patients
Libera, D. D., Mitri, D. D., Bergami, A., Centonze, D., Gasperini, C., Grasso, M. G., Galgani, S., Martinelli, V., Comı, G., Avolio, C., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021386 · Cited by 90
“Recent studies, however, show that ectopic expression of FoxP3 in mouse CD4 T cells is not sufficient to generate Tregs in vitro, and transient FoxP3 expression has been demonstrated in recently activated T cells [24,27,28].”
BackgroundResultExpansion of FOXP3-positive CD4+CD25+ T cells associated with disease activity in atopic dermatitis
Ito, Y., Adachi, Y., Makino, T., Higashiyama, H., Fuchizawa, T., Shimizu, T., & Miyawaki, T. (2009) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)60170-6 · Cited by 86
Zheng, Y., Manzotti, C. N., Burke, F., Dussably, L., Qureshi, O., Walker, L. S. K., & Sansom, D. M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.3.1683 · Cited by 86
“The results have led to the conclusion that because these cytokines are still transcribed in FoxP3 cells, FoxP3 is therefore not functionally active (8, 22).”
BackgroundResultInfluentialSeyerl, M., Kirchberger, S., Majdic, O., Seipelt, J., Jindra, C., Arnold‐Schrauf, C., & Stöckl, J. (2009) · European Journal of Immunology · doi:10.1002/eji.200939527 · Cited by 101
Defect of regulatory T cells in patients with Omenn syndrome
Cassani, B., Poliani, P. L., Moratto, D., Sobacchi, C., Marrella, V., Imperatori, L., Vairo, D., Plebani, A., Giliani, S., Vezzoni, P., et al. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.10.023 · Cited by 90
Human CD4 + FOXP3 + regulatory T cells produce CXCL8 and recruit neutrophils
Himmel, M. E., Crome, S. Q., Ivison, S. M., Piccirillo, C. A., Steiner, T. S., & Levings, M. K. (2011) · European Journal of Immunology · doi:10.1002/eji.201040459 · Cited by 97
Self-citationRegulatory T cells in solid organ transplantation
Atif, M., Conti, F., Gorochov, G., Oo, Y. H., & Miyara, M. (2020) · Clinical & Translational Immunology · doi:10.1002/cti2.1099 · Cited by 86
Burl, S., Adetifa, U. J., Cox, M., Touray, E. S., Ota, M. O. C., Marchant, A., Whittle, H. C., McShane, H., Rowland‐Jones, S., & Flanagan, K. L. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000552 · Cited by 82
“FOXP3 expression is known to be transiently upregulated in effector T cells after activation, but levels then decline and remaining FOXP3 cells are thought to represent true Tregs (52).”
BackgroundHarnessing the biology of regulatory T cells to treat disease
Wardell, C. M., Boardman, D. A., & Levings, M. K. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01089-x · Cited by 100
“These contrasting results likely arise from differences in the lineage-tracing systems used and because FOXP3 is transiently expressed in activated effector T cells that could be present in putative T reg cell populations 33 .”
Self-citationHilchey, S. P., Kobie, J. J., Cochran, M. R., Secor‐Socha, S., Wang, J.-C. E., Hyrien, O., Burack, R., Mosmann, T. R., Quataert, S. A., & Bernstein, S. H. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900475 · Cited by 92
“4, D and E, the proportion of CD3 T cells that are CD4 CD25highFOXP3 Tregs is indeed significantly greater in FL nodes as compared with that of NLN, RLN, as well as peripheral blood.”
BackgroundInfluentialPeripheral and Thymic Foxp3+ Regulatory T Cells in Search of Origin, Distinction, and Function
Dhamne, C. A., Chung, Y., Alousi, A. M., Cooper, L. J. N., & Tran, D. Q. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00253 · Cited by 90
“In addition, McClymont et al. have shown that the IFNγ+ Tregs from patients with type 1 diabetes are Helios− and predominately methylated at the TSDR.”
BackgroundInfluentialThe role of regulatory T cells in neurodegenerative diseases
HeFeng, F. Q., & Balling, R. (2013) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1187 · Cited by 79
Are CD4+CD25-Foxp3+cells in untreated new-onset lupus patients regulatory T cells?
Yang, H.-X., Zhang, W., Zhao, L.-D., Li, Y., Zhang, F.-C., Tang, F.-L., He, W., & Zhang, X. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2829 · Cited by 79
“Foxp3 is also expressed on some activated CD4+ T cells [12].”
Nowak, A., Lock, D., Bacher, P., Hohnstein, T., Vogt, K., Gottfreund, J., Giehr, P., Polansky, J. K., Sawitzki, B., Kaiser, A., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00199 · Cited by 78
Treg stability: to be or not to be
Overacre, A. E., & Vignali, D. A. (2016) · Current Opinion in Immunology · doi:10.1016/j.coi.2015.12.009 · Cited by 78
“Transient Foxp3 expression has also been observed in human T cells, although these cells have no suppressive function [25].”
BackgroundA novel function for FOXP3 in humans: intrinsic regulation of conventional T cells
McMurchy, A. N., Gillies, J., Gizzi, M. C., Riba, M., Garcia-Manteiga, J. M., Cittaro, D., Lazarevic, D., Di Nunzio, S., Piras, I. S., Bulfone, A., et al. (2013) · Blood · doi:10.1182/blood-2012-05-431023 · Cited by 77
Self-citationMechanisms of tolerance induction in allergic disease: integrating current and emerging concepts
Wiśniewski, J., Agrawal, R., & Woodfolk, J. A. (2013) · Clinical & Experimental Allergy · doi:10.1111/cea.12016 · Cited by 89
Rimbert, M., Hamidou, M. A., Braudeau, C., Puéchal, X., Teixeira, L., Caillon, H., Néel, A., AUDRAIN, M. A. P., Guillevin, L., & Josien, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018734 · Cited by 79
“effector [42].”
Metadata
- Authors
- Allan, S. E., Crome, S. Q., Crellin, N. K., Passerini, L., Steiner, T. S., Bacchetta, R., Roncarolo, M. G., & Levings, M. K.
- Affiliations
- University of British Columbia (CA)
- The San Raffaele Telethon Institute for Gene Therapy (IT)
- Vita-Salute San Raffaele University (IT)
- Venue
- International Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-02-20
- Volume
- 19
- Issue
- 4
- Pages
- 345-354
- ISSN
- 0953-8178 (ISSN-L)
- 1460-2377
- OpenAlex
- W2139019810
- Cited by
- 872
- References
- 39
- Citations by year
- 2026: 13 · 2025: 24 · 2024: 24 · 2023: 21 · 2022: 25 · 2021: 33 · 2020: 22 · 2019: 34 · 2018: 34 · 2017: 36 · 2016: 26 · 2015: 46 · 2014: 62 · 2013: 62 · 2012: 67
- FWCI
- 34.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Immunology (publishedVersion)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- Foxp3, CD4+CD25+ T cells, T cell activation, T cell proliferation, cytokine production, CD127, interleukin-2, interferon-gamma, immune tolerance, human T cells
- MeSH terms
- CD69 Antigens, Antibodies, Antigens, Differentiation, Antigens, Differentiation, T-Lymphocyte, Cell Line, Cysteine, Flagellin, Humans, Interferon-gamma, Interleukin-2, Lipoproteins, Lymphocyte Activation, CD4-Positive T-Lymphocytes, Antigens, CD, T-Lymphocyte Subsets, Cytokines, CD3 Complex, Receptors, Nerve Growth Factor, Clonal Anergy, CD28 Antigens, Receptors, Tumor Necrosis Factor, Coculture Techniques, Lectins, C-Type, Cell Proliferation, T-Lymphocytes, Regulatory, Toll-Like Receptors, Forkhead Transcription Factors, Glucocorticoid-Induced TNFR-Related Protein, Interleukin-2 Receptor alpha Subunit, Interleukin-7 Receptor alpha Subunit, CTLA-4 Antigen
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.